Despite major advancements in cardiovascular medicine, sudden cardiac death (SCD)
continues to be an enormous medical and societal challenge, claiming millions of lives …

Background Chatbots are being piloted to draft responses to patient questions, but patients'
ability to distinguish between provider and chatbot responses and patients' trust in chatbots' …

Artificial intelligence (AI) is increasingly used in electrocardiography (ECG) to assist in
diagnosis, stratification, and management. AI algorithms can help clinicians in the following …

Artificial intelligence (AI) can detect left ventricular systolic dysfunction (LVSD) from
electrocardiograms (ECGs). Wearable devices could allow for broad AI-based screening but …

Recent years have witnessed significant transformations in cardiovascular medicine, driven
by the rapid evolution of artificial intelligence (AI). This scoping review was conducted to …

Traditional measures of clinical status and physiology have generally been based in health
care settings, episodic, short in duration, and performed at rest. Wearable biosensors …

Aims Cardiotoxicity is a serious side effect of anthracycline treatment, most commonly
manifesting as a reduction in left ventricular ejection fraction (EF). Early recognition and …

Cardiovascular diseases represent a significant threat to the overall well‐being of the global
population. Continuous monitoring of vital signs related to cardiovascular health is essential …

Inherited arrhythmia disorders account for a significant proportion of sudden cardiac death,
particularly among young individuals. Recent advances in our understanding of these …

Background: Left heart abnormalities are risk factors for heart failure. However,
echocardiography is not always available. Electrocardiograms (ECGs), which are now …